| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 467.82B | 497.85B | 497.59B | 477.40B | 450.36B |
| Gross Profit | 332.06B | 334.86B | 336.65B | 342.26B | 327.22B |
| EBITDA | 194.38B | 194.24B | 192.06B | 179.72B | 161.70B |
| Net Income | 150.18B | 148.39B | 146.60B | 138.01B | 119.92B |
Balance Sheet | |||||
| Total Assets | 13.07T | 12.15T | 11.03T | 10.14T | 9.25T |
| Cash, Cash Equivalents and Short-Term Investments | 1.97T | 2.10T | 1.07T | 960.91B | 846.62B |
| Total Debt | 405.44B | 471.07B | 436.55B | 455.39B | 631.11B |
| Total Liabilities | 11.79T | 10.92T | 9.94T | 9.18T | 8.38T |
| Stockholders Equity | 1.27T | 1.23T | 1.08T | 945.50B | 858.75B |
Cash Flow | |||||
| Free Cash Flow | 423.32B | 412.09B | 327.59B | 535.25B | 157.89B |
| Operating Cash Flow | 451.46B | 447.02B | 357.75B | 570.14B | 182.05B |
| Investing Cash Flow | -324.92B | -292.86B | -255.11B | -513.93B | -19.70B |
| Financing Cash Flow | -169.94B | 2.15B | -72.99B | -297.03B | 89.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.17T | 8.32 | 11.95% | 4.26% | -4.57% | 1.77% | |
71 Outperform | HK$462.45B | 10.39 | 11.77% | 5.80% | 1.90% | 12.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | HK$506.25B | 5.02 | 9.01% | 5.76% | -5.46% | 0.33% | |
57 Neutral | HK$210.57B | 5.64 | 6.61% | 5.53% | -8.41% | -5.52% | |
57 Neutral | HK$649.95B | 6.72 | 9.30% | 5.37% | -1.54% | -3.95% | |
52 Neutral | HK$182.90B | 5.60 | 4.68% | 9.09% | -7.28% | -5.00% |